Jump to Main Content

Programs

Special Interest Sessions

ASH Choosing Wisely® Campaign: 2020 ASH Choosing Wisely Champions

In cooperation with the ABIM Foundation, ASH has introduced the Choosing Wisely Champions initiative to recognize the efforts of practitioners who are working to eliminate costly and potentially harmful overuse of tests and procedures. Each year, three individuals are invited to present on successful utilization strategies that they have developed and implemented in their practice, institution, or hospital system. This provides an opportunity for clinicians, administrators, and other medical professionals to learn about projects that might be translated to their own practices.

Chair:

Anita Rajasekhar, MD
University of Florida - Shands Hospital
Gainesville, FL

back to top

ASH Consultative Hematology Course

The ASH Consultative Hematology Course (CHC) is an interactive, half-day program led by faculty familiar with consultative practice issues and commonly encountered clinical problems that require the expertise of a hematologist. Program participants engage in case-based presentations and discussions focusing on non-malignant hematology topics, such as thrombosis, thrombocytopenia, and bleeding. For more information, visit https://www.hematology.org/CHC/Program/.

If you are interested in registering for this course but are not planning to register for the annual meeting, please contact ashregistration@spargoinc.com. Advance online registration is limited to clinical hematologists practicing in North America; on-site registration will be possible for other groups if space is available.

The American Society of Hematology (ASH) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.

ASH designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Co-Chairs:

Jacquelyn M. Powers, MD,MSc
Baylor College of Medicine/ Texas Children's Hospital
Houston, TX

Shruti Chaturvedi, MBBS,MS
Johns Hopkins University School of Medicine
BALTIMORE, MD

Speakers:

Adam Cuker, MD,MS
Perelman School of Medicine
Philadelphia, PA
Hematologic Complications in Pregnancy

Amanda M. Brandow, DO, MS
Medical College of Wisconsin
Milwaukee, WI
Updates in Managing Pain in Sickle Cell Disease

Ang Li, MD
Baylor College of Medicine
Houston, TX
Doacs in Special Populations (Cancer +/- Obesity)

Jacquelyn M. Powers, MD,MSc
Baylor College of Medicine/ Texas Children's Hospital
Houston, TX
Transfusion Medicine (Adverse Events and Patient Blood Management)

Shruti Chaturvedi, MBBS,MS
Johns Hopkins University School of Medicine
BALTIMORE, MD
Thrombocytopenia in the Hospitalized Patient

Daria V. Babushok, MD, PhD
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA
PNH and Aplastic Anemia Updates

Panelists:

Daria V. Babushok, MD, PhD
Hospital of the University of Pennsylvania
Philadelphia, PA

Amanda M. Brandow, DO, MS
Medical College of Wisconsin
Milwaukee, WI

Shruti Chaturvedi, MBBS,MS
Johns Hopkins University School of Medicine
BALTIMORE, MD

Adam Cuker, MD,MS
University of Pennsylvania
Philadelphia, PA

Ang Li, MD
Baylor College of Medicine
Houston, TX

Jacquelyn M. Powers, MD,MSc
Baylor College of Medicine/ Texas Children's Hospital
Houston, TX

back to top

ASH Foundation Run/Walk

Join us for an invigorating 3K or 5K run or walk at the ASH annual meeting. This year's course will take place on the scenic Embarcadero, starting and finishing in the Embarcadero Marina Park South. All proceeds from registration fees and donations will benefit the ASH Restart Award. Come out and run or walk for a good cause.

Schedule

7:00 a.m.             Race day packet pickup; no on-site registration

7:15 a.m.             Warm-up

7:30 a.m.             Race starts

8:30 a.m.             Race ends (approximately 8:30 a.m. or when the last participant finishes)

back to top

ASH Practice Partnership Lunch Program

o CAM or Not To, That is the Question; Complementary and Alternative Medicine in Hematology

According to the National Cancer Institute, complementary and alternative medicine (CAM) is defined as medical products and practices that are not part of standard medical care. Alternative medicine, such as a specialized diet or other naturopathy, is used in lieu of standard medicine while complementary medicine, such as using acupuncture to help lessen some side effects of cancer treatment, is used along with standard medical treatments. While some CAM therapies, after careful evaluation, have been found to be safe and effective, research on others has been slow due to issues such as time, funding, and the ability to identify willing institutions and researchers. Additionally, some CAM therapies, such as medical marijuana, have run into regulatory hurdles, and there is little communication about CAM use among patients, CAM providers, and hematologists. Nevertheless, CAM is common among hematology patients, who, for example, use the analgesic properties of medical marijuana for cancer and sickle cell disease, but also for many who use these unconventional therapies to gain hope and improve quality of life.

This session will provide information about CAM therapies that may be discussed by patients with their hematologist. Additionally, the session will address the most common questions physicians hear from their patients about CAM therapies and how to conduct a constructive conversation between the physician and patient.

Moderator:

Chancellor E Donald, MD
Tulane University School of Medicine
New Orleans, LA

Speakers:

Bipin N. Savani, MD
Vanderbilt University
Brentwood, TN
Nutritional Supplements and Complementary/Alternative Medical Practices in Patients with Hematologic Diseases

Ilana Braun, MD
Dana-Farber Cancer Institute
Boston, MA
The Role Medical Marijuana Plays in Cancer Care; A Focus on Clinical Trial Evidence

Shawn Seibert, MD
Illinois Cancercare
Peoria, IL
Conversations and the Education of Physicians and Patients

back to top

Hemostasis and Thrombosis Poster Walk for Trainees

This is an intimate and exclusive event where trainees will have the opportunity to network with leaders in the field of hemostasis and thrombosis. The walk includes key opinion leaders who will lead small groups of trainees through a curated set of hemostasis and thrombosis focused posters in the Poster Hall. This will be followed by a panel discussion with a continental breakfast in a dedicated theater.

This is a ticketed session. Tickets can be obtained on site at registration. Tickets are restricted to trainees only and are available on a first-come, first-served basis.

back to top

Special Education Session on AML MATTERS

back to top

Special Education Session on ASH Clinical Practice Guidelines on Acute Myeloid Leukemia in Older Adults

In 2017 ASH initiated its first guideline development effort on a malignant topic: acute myeloid leukemia in older adults. This topic was selected as clinically important and largely unaddressed by existing guidelines. Development of these guidelines, including systematic evidence review, was supported by the McMaster University GRADE Centre. Publication of the guidelines in Blood Advances is expected in mid-2020.

In this special session, speakers will highlight particularly notable recommendations and will discuss important considerations for the practical application of the recommendations in practice. 

Chair:

Mikkael A. Sekeres
Cleveland Clinic Taussig Cancer Institute
Cleveland, OH

Speaker:

Mikkael A. Sekeres
Cleveland Clinic Taussig Cancer Institute
Cleveland, OH
Introduction and Overview of ASH AML Guidelines

back to top

Special Education Session on ASH Clinical Practice Guidelines on Sickle Cell Disease

In 2016, ASH initiated the development of five clinical practice guidelines on sickle cell disease, addressing acute and chronic complications of the disease as well as stem cell transplantation. The first four guidelines, on cardiopulmonary and kidney Disease, transfusion support, cerebrovascular disease, and acute and chronic pain have been published in Blood Advances, with the remaining stem cell transplantation chapter scheduled for submission to Blood Advances later in 2020.

In this special session, speakers will highlight particularly notable recommendations from the SCD guidelines and will discuss important considerations for the practical application of the recommendations in practice, including a focus on dissemination and implementation strategies. 

Chair:

Robert I. Liem, MD
Lurie Children's Hospital
Chicago, IL

Speakers:

Ifeyinwa (IFY) Osunkwo, MD, MPH
Sickle Cell Disease Enterprise at The Levine Cancer Institute/Atrium Health
Charlotte, NC
ASH Clinical Practice Guidelines on Sickle Cell Disease

Ted Wun, MD
UC Davis Comprehensive Cancer Center
Sacramento, CA
ASH Clinical Practice Guidelines on Sickle Cell Disease

John J. Strouse, MD, PhD
Duke University School of Medicine
Durham, NC
ASH Clinical Practice Guidelines on Sickle Cell Disease

back to top

Special Education Session on ASH Clinical Practice Guidelines on Venous Thromboembolism

Seven ASH clinical practice guidelines on VTE have been published in Blood Advances, and four others are planned for submission to Blood Advances in 2020 (treatment of VTE, prevention and treatment of cancer-associated thrombosis, thrombophilia testing, and a special adaption of the VTE guidelines for Latin America).

In this special session, speakers will highlight particularly notable recommendations from the VTE guidelines and will discuss important considerations for the practical application of the recommendations in practice, including a focus on dissemination and implementation strategies.  

Chair:

Adam Cuker, MD,MS
University of Pennsylvania
Philadelphia, PA

Speakers:

Adam Cuker, MD,MS
University of Pennsylvania
Philadelphia, PA
ASH COVID-19 Guidelines

Marc Carrier, MD
University of Ottawa
Ottawa, ON, Canada
ASH Clinical Practice Guidelines on Venous Thromboembolism

Saskia Middeldorp, MD, PhD
Academic Medical Center
Amsterdam, Netherlands
ASH Clinical Practice Guidelines on Venous Thromboembolism

Ignacio Neumann
Pontificia Universidad Católica de Chile
Santiago, Chile
ASH Clinical Practice Guidelines on Venous Thromboembolism

Peter Verhamme, MD, PhD
Department of Cardiovascular Sciences, Universitaire Ziekenhuizen
Leuven, Belgium
ASH Clinical Practice Guidelines on Venous Thromboembolism

back to top

Special Education Session on ASH Clinical Practice Guidelines on von Willebrand Disease

The American Society of Hematology is collaborating with the International Society on Thrombosis and Haemostasis, National Hemophilia Foundation, World Federation of Hemophilia, and Kansas University Medical Center to develop clinical practice guidelines on the diagnosis and management of von Willebrand Disease (VWD).

In this special session, speakers will highlight particularly notable recommendations and will discuss important considerations for the practical application of the recommendations in practice. 

Co-Chairs:

Paula D. James, MD,FRCPC
Queen's University
Kingston, ON, Canada

Veronica H Flood, MD
Medical College of Wisconsin
Milwaukee, WI

Nathan T. Connell, MD,MPH
Brigham and Women's Hospital
Boston, MA

back to top

Special Symposium on Quality: Blood, Debt and Tears: Tackling Burnout in Hematology

This novel, 90 minute session will highlight four big ideas tackling burnout in Hematology.  Trainees will be invited to submit a 500-word summary of their idea to improve clinician and trainee well-being.  Four finalists will be invited to present their “big idea” in a 5-minute, TED-talk-style presentation.  Each of the four finalists will then have 5 to 10 minutes to answer questions from expert judges and from the audience.  Presenters will be judged on their idea, their presentation, and on how they answer questions. An over-all winner and an audience favorite will be selected and awarded cash prizes.

The session will be anchored by an introductory talk on physician-burnout from a recognized expert and public speaker, who will frame the problem and some of its drivers, setting the stage for big ideas from the next generation.  

Co-Chairs:

Lisa K. Hicks, MD, MSc
St. Michael's Hospital
Toronto, ON, Canada

Sarah H. O'Brien, MD
Nationwide Children's Hospital
Columbus, OH

Speakers:

Shelly Dev
Sunnybrook Health Sciences Center
Toronto, ON, Canada
Physician Burnout

Shelly Dev
Sunnybrook Health Sciences Center
Toronto, ON, Canada
Judges Panel

Robert S. Negrin, MD
Stanford University
Stanford, CA
Judges Panel

Alexis A. Thompson, MD
Northwestern University
Chicago, IL
Judges Panel

back to top

Systems-Based Hematology: How to Implement Evidence-Based Programs for Perioperative Anemia and Blood Management, and Bloodless Medicine

The systems-based hematologist is defined as "a specialty-trained physician, employed by a hospital, medical center, or health system, who optimizes individual patient care, as well as the overall system of health care delivery for patients with blood disorders."  Physicians who fill this role for health systems lead efforts to improve quality of care along with cost savings, but often face challenges in implementing change and receiving financial support. This session will highlight the defining characteristics of the systems-based hematologist, and experts working in the field will provide a comprehensive overview of the how to implement evidence-based projects in perioperative anemia and bloodless medicine.

After the formal program, attendees will be invited to spend one-hour networking with others in the systems-based hematology community.  Drinks and light hors d'oeuvres will be provided.

Chair:

Marc Stuart Zumberg, MD
University of Florida
Gainesville, FL

Speakers:

Marc Stuart Zumberg, MD
University of Florida
Gainesville, FL
Introduction to Systems-Based Hematology

Colleen Morton, MD
Vanderbilt University
Nashville, TN
How I Setup a Perioperative Blood Management and Perioperative Anemia Evaluation Program

Bruce Spiess
University of Florida College of Medicine
Gainesville, FL
How I Setup a Bloodless Medicine Program

back to top

Training Program Directors' Workshop

Chair:

Srikanth Nagalla, MBBS,MS
UT Southwestern
Dallas, TX

Speakers:

Emery H Bresnick, PhD
University of Wisconsin
Middleton, WI
Mentorship

Hetty E. Carraway, MD, MBA
Cleveland Clinic Foundation
Cleveland, OH
Mentorship

Alfred Ian Lee, MD, PhD
Yale University
Hamden, CT
Update on Recruitment and Retention

Rakhi P. Naik, MD
Johns Hopkins Hospital
Baltimore, MD
Update on Recruitment and Retention

Martina C. Murphy, MD
UF Hematology/Oncology
Gainesville, FL
Best Practices in Curriculum/Conferences

Srikanth Nagalla, MBBS,MS
UT Southwestern
Philadelphia, PA
Best Practices in Curriculum/Conferences

Gerald A. Soff, MD
Memorial Sloan-Kettering Cancer Center
New York City, NY
Best Practices in Curriculum/Conferences